OSMR is a cell surface receptor that is a key component of EGFRvIII-STAT3 signaling, which forms a feedforward signaling mechanism with these molecules to drive glioblastoma genesis and progression (Jahani-Asl et al., 2016). Here, CD177 is linked to glioblastoma.